Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec-Reference-Cited by-同舟云学术

Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec

Published:2017-07 Issue:4 Volume:3 Page:280-283
ISSN:2352-5126
Container-title:JAAD Case Reports
language:en
Short-container-title:JAAD Case Reports

Author:

Blackmon Jonathan T.,Stratton Michael S.,Kwak Young,Pavlidakey Peter G.,Slominski Andrzej T.,McKee Svetlana B.,Viator Toni M.,Kim Ju Young,Huang Conway C.,Conry Robert M.^ORCID

Publisher

Elsevier BV

Subject

Dermatology

Reference10 articles.

1. Inflammatory melanoma;Haupt;J Am Acad Dermatol,1984

2. Melanoma erysipeloides: inflammatory metastatic melanoma of the skin;Tan;Br J Dermatol,1993

3. Inflammatory metastatic melanoma;Florez;J Cutan Pathol,1999

4. Inflammatory melanoma: a potential diagnostic pitfall;Wilsher;Pathology,2010

5. Bordeaux J. Novel Quantitative Multiplexed PD-1/PD-L1 Immunohistochemistry Test Provides Superior Prediction of Treatment Response in Melanoma Patients. AACR Oral Presentation, 2016.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erysipela-like primary cutaneous melanoma;Italian Journal of Dermatology and Venereology;2023-03

2. Non-Operative Options for Loco-regional Melanoma;Clinics in Plastic Surgery;2021-10

3. Melanoma Diagnosis and Treatment in the Elderly;Current Geriatrics Reports;2020-11-11

4. Review of talimogene laherparepvec: A first-in-class oncolytic viral treatment of advanced melanoma;Journal of the American Academy of Dermatology;2020-07

5. Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma;Melanoma Research;2019-02